Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies.
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.
Pathophysiology of immune-mediated demyelinating neuropathies - Part II: Neurology.
2nd International Symposium on Gait and Balance in Multiple Sclerosis: interventions for gait and balance in MS.
Induction and molecular signature of pathogenic T(H)17 cells.
Multiple sclerosis databases: present and future.
NMDA receptor antibodies associated with distinct white matter syndromes.
Can we measure long-term treatment effects in multiple sclerosis?
Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL.
The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels.
Neurodegenerative diseases and therapeutic strategies using iron chelators.
Neuroimmunology: Cyclosporine A and azathioprine are effective adjunctive treatments for neuromyelitis optica.
Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis.
A qualitative review of the neurophysiological underpinnings of fatigue in multiple sclerosis.
Lymphomatosis cerebri Presenting as a Recurrent Leukoencephalopathy.
Increased Plasma Interleukin-32 Expression in Patients with Neuromyelitis Optica.
"Seeing" in NARCOMS: a look at vision-related quality of life in the NARCOMS registry.
[Pay attention to the related advances of demyelinating diseases in the central nervous system].
Identity-by-Descent Mapping to Detect Rare Variants Conferring Susceptibility to Multiple Sclerosis.
Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: A pilot study.
Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease.
Retrieval practice is a robust memory aid for memory-impaired patients with MS.
Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Olfactory Pathology in Central Nervous System Demyelinating Diseases.
Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosis.

Pages